Start-up ZYMOPTIQ wins Bpifrance’s i-Démo prize!

Congratulations to ZYMOPTIQ for its technological excellence in enzyme analysis.
The i-Démo prize from Bpifrance will enable the company to consolidate its leadership in the enzyme analysis segment in strategic industries such as cereals, food and animal nutrition.

To mark the occasion, the start-up had the honour of presenting its latest commercial advances in France and abroad to :

Regis Bordet, President of the University of Lille.
Philippe Beauchamps, Vice-President of the Hauts-de-France Region, responsible for business, employment and training.
Olivier Colot, Vice-President of Research.
Etienne Vervaecke, Managing Director of Eurasanté and Clubster NSL.
Jean Louis Guerin, Managing Director of FINORPA.
Eric Bernos, Investment Director Captech Santé Nutrition at FINORPA.

ZYMOPTIQ is the result of many years‘ research in microtechnology at the IEMN research unit.

To find out more about its activities:
https://zymoptiq.com

© Crédits photo : ZYMOPTIQ